Native glycan fragments detected by MALDI-FT-ICR mass spectrometry imaging impact gastric cancer biology and patient outcome

Thomas Kunzke, Benjamin Balluff, Annette Feuchtinger, Achim Buck, Rupert Langer, Birgit Luber, Florian Lordick, Horst Zitzelsberger, Michaela Aichler, Axel Walch*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)68012-68025
Number of pages14
JournalOncotarget
Volume8
Issue number40
DOIs
Publication statusPublished - 15 Sep 2017

Keywords

  • glycans
  • gastric cancer
  • formalin-fixed paraffin-embedded tissue
  • MALDI
  • mass spectrometry imaging
  • TN ANTIGEN EXPRESSION
  • PROGNOSTIC-SIGNIFICANCE
  • LUNG-CANCER
  • GLYCOSYLATION
  • GROWTH
  • METABOLITES
  • ACTIVATION
  • SULFATES
  • TISSUE
  • STROMA

Cite this

Kunzke, T., Balluff, B., Feuchtinger, A., Buck, A., Langer, R., Luber, B., Lordick, F., Zitzelsberger, H., Aichler, M., & Walch, A. (2017). Native glycan fragments detected by MALDI-FT-ICR mass spectrometry imaging impact gastric cancer biology and patient outcome. Oncotarget, 8(40), 68012-68025. https://doi.org/10.18632/oncotarget.19137